title: United States Public Health Service Tuberculosis Therapy Trial 21: preliminary results of an evaluation of a combination tablet of isoniazid, rifampin and pyrazinamide.
authors.affiliation: Division of Tuberculosis Control, Centers for Disease Control, Atlanta, Georgia 30333.
authors.forename: L J
authors.initials: LJ
authors.lastname: Geiter
authors.forename: R J
authors.initials: RJ
authors.lastname: O'Brien
authors.forename: D L
authors.initials: DL
authors.lastname: Combs
authors.forename: D E
authors.initials: DE
authors.lastname: Snider
mesh_terms: D002986:Clinical Trials as Topic; D004338:Drug Combinations; D005260:Female; D006801:Humans; D007538:Isoniazid / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D010349:Patient Compliance; D011718:Pyrazinamide / Q000009:adverse effects / Q000627:therapeutic use*; D011897:Random Allocation; D012293:Rifampin / Q000009:adverse effects / Q000627:therapeutic use*; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
chemical_list: D004338:Drug Combinations; D011718:Pyrazinamide; D007538:Isoniazid; D012293:Rifampin